• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在金属结合基序中半胱氨酸被甘氨酸取代的16型人乳头瘤病毒E6蛋白

Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif.

作者信息

Kanda T, Watanabe S, Zanma S, Sato H, Furuno A, Yoshiike K

机构信息

Department of Enteroviruses, National Institute of Health, Tokyo, Japan.

出版信息

Virology. 1991 Dec;185(2):536-43. doi: 10.1016/0042-6822(91)90523-e.

DOI:10.1016/0042-6822(91)90523-e
PMID:1660194
Abstract

The human papillomavirus type 16 (HPV 16) E6 is a 151 amino acid protein containing four metal-binding motifs, Cys-X-X-Cys. We constructed and characterized three mutants with Gly substitutions for Cys within the motif; for Cys-66, for Cys-136, and for both, respectively. Zinc binding to bacterially expressed E6 was markedly reduced by the substitution for Cys-66, but DNA binding was unaffected by any of these mutations. Immunofluorescence staining showed that, whereas the E6 expressed in monkey COS-1 cells appeared mostly nuclear, the Cys-66 mutant appeared cytoplasmic. Subcellular fractionation followed by immunoprecipitation showed that the E6 in COS-1 cells was located in the membrane, nuclear, and nuclear-wash fractions, but not in the soluble cytoplasmic fraction, and that the nuclear Cys-66 protein was markedly reduced. The mutant proteins in COS-1 cells appeared to be less stable than the wild type, because the immunofluorescent cells were fewer and because the E6 bands in autoradiograms were less dense. The substitution mutants lost their capacity to enhance HPV 16 E7 transformation of rat 3Y1 cells. The data indicate that Cys-66 plays a crucial role for zinc binding and nuclear localization of E6 and that both Cys-66 and Cys-136 are required for a stable or functional structure of E6.

摘要

人乳头瘤病毒16型(HPV 16)E6是一种含151个氨基酸的蛋白质,包含四个金属结合基序Cys-X-X-Cys。我们构建并表征了三个突变体,分别用甘氨酸取代该基序中的半胱氨酸,即分别取代Cys-66、Cys-136以及同时取代两者。用甘氨酸取代Cys-66后,细菌表达的E6与锌的结合显著减少,但DNA结合不受这些突变中任何一个的影响。免疫荧光染色显示,在猴COS-1细胞中表达的E6大多出现在细胞核中,而Cys-66突变体则出现在细胞质中。通过亚细胞分级分离后进行免疫沉淀显示,COS-1细胞中的E6位于膜、细胞核和核洗液部分,但不在可溶性细胞质部分,并且细胞核中的Cys-66蛋白明显减少。COS-1细胞中的突变蛋白似乎比野生型更不稳定,因为免疫荧光细胞较少,并且放射自显影片中的E6条带密度较低。取代突变体失去了增强HPV 16 E7对大鼠3Y1细胞转化的能力。数据表明,Cys-66对E6的锌结合和核定位起着关键作用,并且Cys-66和Cys-136对于E6的稳定或功能结构都是必需的。

相似文献

1
Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif.在金属结合基序中半胱氨酸被甘氨酸取代的16型人乳头瘤病毒E6蛋白
Virology. 1991 Dec;185(2):536-43. doi: 10.1016/0042-6822(91)90523-e.
2
Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.人乳头瘤病毒16型E6蛋白的突变分析:对人细胞的转化功能及体外p53降解
Virology. 1995 Oct 1;212(2):535-42. doi: 10.1006/viro.1995.1511.
3
Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7.通过对人乳头瘤病毒E7进行共识预测平均法和光谱学研究,预测人乳头瘤病毒E7和E6蛋白锌结合基序的α-螺旋/β-折叠二级结构。
Biochem J. 1996 Oct 1;319 ( Pt 1)(Pt 1):229-39. doi: 10.1042/bj3190229.
4
Changing the spacing between metal-binding motifs decreases stability and transforming activity of the human papillomavirus type 18 E7 oncoprotein.改变金属结合基序之间的间距会降低人乳头瘤病毒18型E7癌蛋白的稳定性和转化活性。
Virology. 1992 Oct;190(2):872-5. doi: 10.1016/0042-6822(92)90928-i.
5
Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding.人乳头瘤病毒18型E7蛋白需要完整的半胱氨酸- X - X -半胱氨酸基序来结合锌、形成二聚体和实现转化,但结合Rb则不需要。
J Virol. 1993 Jun;67(6):3142-50. doi: 10.1128/JVI.67.6.3142-3150.1993.
6
Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.E6和E7蛋白在低风险11型人乳头瘤病毒生命周期中的作用。
J Virol. 2004 Mar;78(5):2620-6. doi: 10.1128/jvi.78.5.2620-2626.2004.
7
Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.在宫颈癌细胞中,通过表达针对人乳头瘤病毒转化蛋白的反义E6和E7信使核糖核酸(mRNA)以及视网膜母细胞瘤基因的正义mRNA的转录单位来抑制肿瘤发生。
Cancer Gene Ther. 1995 Mar;2(1):19-32.
8
[Modification of HPV type 16 E6 and E7 genes, and analysis of stability and immunogenicity of the modified proteins].[人乳头瘤病毒16型E6和E7基因的修饰以及修饰后蛋白的稳定性和免疫原性分析]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Jun;16(2):124-7.
9
Papillomavirus polypeptides E6 and E7 are zinc-binding proteins.乳头瘤病毒多肽E6和E7是锌结合蛋白。
J Virol. 1989 Mar;63(3):1404-7. doi: 10.1128/JVI.63.3.1404-1407.1989.
10
The carboxyl-terminal zinc-binding domain of the human papillomavirus E7 protein can be functionally replaced by the homologous sequences of the E6 protein.人乳头瘤病毒E7蛋白的羧基末端锌结合结构域可被E6蛋白的同源序列功能性取代。
Virus Res. 1997 Nov;52(1):109-18. doi: 10.1016/s0168-1702(97)00090-7.

引用本文的文献

1
Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?厨房里厨师太多:人乳头瘤病毒驱动的致癌作用——协作还是竞争的结果?
Tumour Virus Res. 2024 Dec 27;19:200311. doi: 10.1016/j.tvr.2024.200311.
2
Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.人乳头瘤病毒相关癌症:最新知识更新。
Viruses. 2021 Nov 6;13(11):2234. doi: 10.3390/v13112234.
3
HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?人乳头瘤病毒癌蛋白与泛素蛋白酶体系统:恶性肿瘤的一种标志?
Pathogens. 2020 Feb 18;9(2):133. doi: 10.3390/pathogens9020133.
4
Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.HPV 相关宫颈癌发生进展中的分子机制。
J Biomed Sci. 2019 Apr 23;26(1):28. doi: 10.1186/s12929-019-0520-2.
5
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites.E6和E7癌蛋白在人乳头瘤病毒(HPV)引发的不同解剖部位恶性肿瘤中的功能作用
Cancers (Basel). 2016 Oct 19;8(10):95. doi: 10.3390/cancers8100095.
6
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer.人乳头瘤病毒:宫颈癌当前及未来的RNA干扰治疗策略
J Clin Med. 2015 May 21;4(5):1126-55. doi: 10.3390/jcm4051126.
7
Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6.p53 的失活挽救了高风险 HPV DNA 基因组的维持,这些基因组在 E6 表达缺陷。
PLoS Pathog. 2013 Oct;9(10):e1003717. doi: 10.1371/journal.ppat.1003717. Epub 2013 Oct 24.
8
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.人类肿瘤病毒中的病毒癌基因、非编码 RNA 和 RNA 剪接。
Int J Biol Sci. 2010 Dec 1;6(7):730-55. doi: 10.7150/ijbs.6.730.
9
The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.EVER蛋白作为抵抗乳头瘤病毒的天然屏障:对人乳头瘤病毒感染发病机制的新见解。
Microbiol Mol Biol Rev. 2009 Jun;73(2):348-70. doi: 10.1128/MMBR.00033-08.
10
Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.人乳头瘤病毒16型E2和E6是RNA结合蛋白,可在体外抑制剪接位点欠佳的前体mRNA的剪接。
Virology. 2009 Mar 30;386(1):32-43. doi: 10.1016/j.virol.2008.12.037. Epub 2009 Feb 1.